Log In
BCIQ
Print this Print this
 

Caprelsa, vandetanib (ZD6474)

Also known as: Zactima

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionEGFR and VEGF receptor kinase inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1) ; Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor; Epidermal growth factor (EGF) receptor 1 (HER1) (ErbB1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$300.0M

$165.0M

$135.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/27/2015

$300.0M

$165.0M

$135.0M

Get a free BioCentury trial today